Clinical Trial

Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock

Study acronym: EXCHANGE-2
Recruiting
View on ClinicalTrials.gov →
Summary
Randomized, prospective, multicenter, open-label, controlled, parallel-group interventional trial to test the adjunctive effect of therapeutic plasma exchange in patients with early septic shock.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-03; most recent amendment 2025-03-11.
Status change: Not Yet Recruiting → Recruiting 2025-03-11
Trial Details
NCT Number NCT05726825
Lead Sponsor Hannover Medical School
Conditions Septic Shock
Enrollment 274 participants
Start Date 2025-02-19
Primary Completion 2028-02 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2025-03-13